Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

EIP Pharma announces positive results with neflamapimod in two Phase IIa clinical trials of Alzheimer’s disease

Go Top